
Overview
PEX sp. z o.o. is an advisory and research company operating in the Polish healthcare and pharmaceutical market. It provides pharmacy data from a panel covering over 50% of pharmacies in Poland, along with market analyses, research, forecasts and consulting, including Market Access projects. The company is a subsidiary of KAMSOFT S.A. and employs a team of about 80 experts.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $233,492 | |
| Profit allocation | Covers prior losses | |
| Capital expenditure | $118,573 | |
| Planned capital expenditure (next year) | $100,452 | |
| Foreign sales | 1.14% of revenue ($104,616) | |
| Revenue structure | syndykatowe analizy danych |
Filing timeliness
Financial statements were filed on time, on average 73 days early. 3 of 6 audited by a statutory auditor.
- 202516/04/2026
- 202424/03/2025
- 202327/06/2024
- 202228/06/2023
- 202105/05/2022
- 202009/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
- Other publishing activities (59.19.Z)
Offer
- Pharmaceutical market research
- Pharmacy data analyses
- Market forecasts
- Consulting for the pharmaceutical industry
- Market Access services
Websites
The site is available in: Polish and English.
- pexps.plPEX – Twój partner biznesowy na rynku farmaceutycznymWordPress 7.1ElementorGoogle AnalyticsGoogle Tag ManagerRRank MathPPolylangCloudflareLLiteSpeed
Trademarks
The company holds 13 active trademarks registered with the Polish Patent Office. 6 marks have expired or were not registered. The first mark was filed in 1998.
| Mark | Protected until | |
|---|---|---|
| Forecaster PEX (word) | May 16, 2035 | |
| Profiler PEX (word) | May 16, 2035 | |
| Prognozer PEX (word) | May 16, 2035 | |
| PEXmind (word) | Jan 27, 2035 | |
| Launcher (word) | Jan 27, 2035 |
Authorized Representatives
Manner of representation
Each member of the management board has the right to represent the company independently
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 24,400 | $3,295,515.94 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2003-10-29.
61 1050 1012 1000 0090 3041 5393
30 1050 1012 1000 0090 3041 5369
39 1050 1012 1000 0090 3041 5401
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $20,888$20,888 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $19,271$19,271 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $18,817$18,817 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Kantar Polska S.A. | $26,421,441.66 | kantar.com | ||
| Ipsos sp. z o.o. | $24,573,128.66 | ipsos.com | ||
| Minds&Roses sp. z o.o. | $20,574,626.78 | mindsandroses.com | ||
| Biostat sp. z o.o. | $6,243,162.72 | biostat.com.pl | ||
| Opinia24 sp. z o.o. | $5,905,121.28 | opinia24.pl | ||
| PBS sp. z o.o. | $5,570,386.17 | pbs.pl | ||
| IQS sp. z o.o. | $4,866,166.85 | grupaiqs.pl | ||
| Danae sp. z o.o. | $3,857,842.06 | danae.com.pl | ||
| Zymetria sp. z o.o. | $2,880,515.88 | pozmaglos.pl | ||
| ARC Rynek i Opinia sp. z o.o. | $2,647,813.57 | epanel.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-01-03 | Name change (Pex Pharmasequence → Pex) | |
| 2022-09-14 | Address change (Ul. Kłobucka 23, 02-699, Warszawa → Ul. Migdałowa 4d/46, 02-796, Warszawa) | |
| 2021-02-25 | Share capital increase (10,000,000.00 PLN → 12,200,000.00 PLN) | |
| 2020-01-29 | Share capital increase (1,000,000.00 PLN → 10,000,000.00 PLN) | |
| 2017-11-21 | Address change (Ul. Górczewska 30, 01-147, Warszawa → Ul. Kłobucka 23, 02-699, Warszawa) |
FAQ
Last updated: 2026-10-07